Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Rowe

Showing results (131-140 of 365) with videos related to

Pageof 37
Sort By:
Current Alzheimer Research|June 24, 2016
Alzheimer's Disease and the Early Signs of Age-Related Macular DegenerationShaun Frost, Robyn Guymer, Khin Zaw Aung, et al.
Neuropsychologia|May 3, 2011
Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL studyKerryn E Pike, Kathryn A Ellis, Victor L Villemagne, et al.
Plos One|October 3, 2015
Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-MonthsChristine Thai, Yen Ying Lim, Victor L Villemagne, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite scoreYen Ying Lim, Peter J Snyder, Robert H Pietrzak, et al.
Neurology|February 16, 2022
Differential Effects of <i>APOE</i> and Modifiable Risk Factors on Hippocampal Volume Loss and Memory Decline in Aβ- and Aβ+ Older AdultsEmily Rosenich, Lisa Bransby, Nawaf Yassi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2016
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's diseaseRachel F Buckley, Paul Maruff, David Ames, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2022
First-in-Humans Evaluation of <sup>18</sup>F-SMBT-1, a Novel <sup>18</sup>F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive AstrogliosisVictor L Villemagne, Ryuichi Harada, Vincent Doré, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 8, 2022
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individualsKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Journal of Alzheimer'S Disease : JAD|May 28, 2017
Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older IndividualsYen Ying Lim, Robert Williamson, Simon M Laws, et al.
Pageof 37

Showing results (131-140 of 365) with videos related to

Sort By:
Pageof 37
Current Alzheimer Research|June 24, 2016
Alzheimer's Disease and the Early Signs of Age-Related Macular DegenerationShaun Frost, Robyn Guymer, Khin Zaw Aung, et al.
Neuropsychologia|May 3, 2011
Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL studyKerryn E Pike, Kathryn A Ellis, Victor L Villemagne, et al.
Plos One|October 3, 2015
Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-MonthsChristine Thai, Yen Ying Lim, Victor L Villemagne, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite scoreYen Ying Lim, Peter J Snyder, Robert H Pietrzak, et al.
Neurology|February 16, 2022
Differential Effects of <i>APOE</i> and Modifiable Risk Factors on Hippocampal Volume Loss and Memory Decline in Aβ- and Aβ+ Older AdultsEmily Rosenich, Lisa Bransby, Nawaf Yassi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2016
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's diseaseRachel F Buckley, Paul Maruff, David Ames, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2022
First-in-Humans Evaluation of <sup>18</sup>F-SMBT-1, a Novel <sup>18</sup>F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive AstrogliosisVictor L Villemagne, Ryuichi Harada, Vincent Doré, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 8, 2022
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individualsKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Journal of Alzheimer'S Disease : JAD|May 28, 2017
Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older IndividualsYen Ying Lim, Robert Williamson, Simon M Laws, et al.
Pageof 37